TSHA — Taysha Gene Therapies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Taysha Gene Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	251	149	87.9	144	139
Prepaid Expenses
Total Other Current Assets
Total Current Assets	258	160	96.4	150	142
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.287	50.6	25.9	20.4	15.9
Other Long Term Assets
Total Assets	259	214	126	173	160
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.13	51.7	62.8	36.8	26.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.58	119	125	97.8	88.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	251	95.4	0.949	74.9	71.5
Total Liabilities & Shareholders' Equity	259	214	126	173	160
Total Common Shares Outstanding